A clinical study for evaluating the safety of excessive consumption of the honey vinegar beverage - A clinical study for evaluating the safety of excessive consumption of the honey vinegar beverage

Soiken Inc.0 sites40 target enrollmentJune 30, 2016

Overview

No summary available.

Registry

who.int

Start Date

June 30, 2016

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

•1\) Subjects who need an urgent anti\-hypertensive treatment 2\) Subjects who have a symptom of cerebrovascular diseases 3\) Heart failure patients or subjects who have a history of myocardial infarction 4\) Subjects who have an atrial fibrillation or a severe arrhythmia 5\) Subjects who have a severe renal dysfunction (serum creatinine \>\=2 mg/dl) 6\) Subjects who have severe hepatic, cardiovascular, respiratory disease, endocrine or metabolic disorders 7\) Subjects who have a history of the hypersensitivity or an allergy for test foods in this study 8\) Subjects who have a secondary hypertension 9\) Subjects who regularly take any anti\-hypertensive drug or FOSHU for improving hypertension 10\) For female: Subjects with pregnant or breast feeding , or those who have a plan to be pregnant during the study period 11\) Subject having blood sample of 200 ml or more taken (e.g., donated blood) within 1 month, or 400 ml or more within 3 months prior to the start of the present study 12\) Subject who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study 13\) Subject deemed unsuitable by the investigator